Discovery and Synthesis of a Naturally Derived Protein Kinase Inhibitor that Selectively Inhibits Distinct Classes of Serine/Threonine Kinases.


Journal

Journal of natural products
ISSN: 1520-6025
Titre abrégé: J Nat Prod
Pays: United States
ID NLM: 7906882

Informations de publication

Date de publication:
27 10 2023
Historique:
medline: 30 10 2023
pubmed: 16 10 2023
entrez: 16 10 2023
Statut: ppublish

Résumé

The

Identifiants

pubmed: 37843072
doi: 10.1021/acs.jnatprod.3c00394
pmc: PMC10616853
doi:

Substances chimiques

Protein Kinase Inhibitors 0
Protein Serine-Threonine Kinases EC 2.7.11.1
Biological Products 0
Serine 452VLY9402
DNAJB1 protein, human 0
HSP40 Heat-Shock Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2283-2293

Subventions

Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States

Références

Pharmacol Res. 2022 Jan;175:106037
pubmed: 34921994
Front Cell Dev Biol. 2021 Oct 28;9:690306
pubmed: 34778245
ACS Pharmacol Transl Sci. 2023 Mar 21;6(4):633-650
pubmed: 37082750
Cell Chem Biol. 2020 Jul 16;27(7):806-816.e8
pubmed: 32359426
Cells. 2021 Mar 16;10(3):
pubmed: 33809714
R Soc Open Sci. 2018 Jun 20;5(6):180333
pubmed: 30110478
J Clin Invest. 2021 Jan 4;131(1):
pubmed: 33393494
ACS Infect Dis. 2021 Mar 12;7(3):518-534
pubmed: 33590753
Cell Mol Life Sci. 2021 Jan;78(2):603-619
pubmed: 32870330
Antiviral Res. 2017 Jul;143:113-121
pubmed: 28400201
Nat Commun. 2011 Nov 29;2:565
pubmed: 22127061
Nat Commun. 2015 Oct 06;6:8070
pubmed: 26437858
Biochem Biophys Res Commun. 2022 Sep 17;621:157-161
pubmed: 35839742
Nat Prod Rep. 2022 Jan 26;39(1):20-32
pubmed: 34342327
Structure. 2019 May 7;27(5):816-828.e4
pubmed: 30905674
J Virol. 2020 Feb 28;94(6):
pubmed: 31852782
Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):72-82
pubmed: 16369096
J Nat Prod. 2020 Mar 27;83(3):770-803
pubmed: 32162523
Pharmacol Ther. 2019 Feb;194:199-221
pubmed: 30268771
Nat Rev Drug Discov. 2021 Jul;20(7):551-569
pubmed: 34002056
Cancer Res. 2007 Apr 15;67(8):3663-72
pubmed: 17440078
Scientifica (Cairo). 2012;2012:743790
pubmed: 24278737
Eur J Pediatr Surg. 2014 Dec;24(6):461-6
pubmed: 25486412
Mol Cancer. 2019 Feb 19;18(1):26
pubmed: 30782187
Molecules. 2010 Jun 24;15(7):4526-63
pubmed: 20657375
Mol Cell Endocrinol. 2014 Apr 5;386(1-2):85-91
pubmed: 24012779
Front Physiol. 2020 Jul 28;11:858
pubmed: 32848832
J Cell Biochem. 2011 May;112(5):1295-310
pubmed: 21312235
Cell Signal. 2017 Dec;40:143-155
pubmed: 28927666
Cancer Cell. 2020 Jul 13;38(1):129-143.e7
pubmed: 32531271
Int J Mol Sci. 2021 Jun 03;22(11):
pubmed: 34205123
J Am Coll Surg. 2012 Dec;215(6):820-30
pubmed: 22981432
PLoS One. 2022 Feb 15;17(2):e0263829
pubmed: 35167623
Angew Chem Int Ed Engl. 2019 Nov 25;58(48):17118-17129
pubmed: 31166642
Nat Rev Drug Discov. 2017 Jan;16(1):19-34
pubmed: 27910877
Endocr Relat Cancer. 2017 Jan;24(1):31-40
pubmed: 27803029
Front Oncol. 2014 May 19;4:96
pubmed: 24904820
J Med Chem. 2021 Mar 25;64(6):2901-2922
pubmed: 33682417
Cancer Res. 2015 Apr 1;75(7):1516-26
pubmed: 25670169
Best Pract Res Clin Endocrinol Metab. 2020 May;34(3):101428
pubmed: 32507359
Cancers (Basel). 2014 Feb 26;6(1):436-58
pubmed: 24577242
Hum Mol Genet. 2015 Jan 1;24(1):50-63
pubmed: 25122662
J Neurochem. 2006 Feb;96(3):635-44
pubmed: 16371011
Br J Pharmacol. 1993 Aug;109(4):1110-9
pubmed: 8401922
Nat Prod Rep. 2013 Oct 11;30(10):1284-98
pubmed: 23925671
Gene. 2020 Oct 20;758:144960
pubmed: 32687947
Science. 2014 Feb 28;343(6174):1010-4
pubmed: 24578576
Expert Opin Ther Targets. 2009 Jan;13(1):83-92
pubmed: 19063708
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
ACS Chem Biol. 2018 Sep 21;13(9):2484-2497
pubmed: 29812901
Clin Cancer Res. 2021 Feb 1;27(3):785-798
pubmed: 33172895
Prog Brain Res. 2020;251:245-268
pubmed: 32057309
J Clin Invest. 2021 Jan 4;131(1):
pubmed: 33393492
Pharmaceuticals (Basel). 2020 Mar 03;13(3):
pubmed: 32138202
FEBS Lett. 2019 Nov;593(21):2953-2965
pubmed: 31505048
Cell Syst. 2018 Sep 26;7(3):347-350.e1
pubmed: 30172842
Sci Adv. 2019 Aug 28;5(8):eaaw9298
pubmed: 31489371
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):13076-13084
pubmed: 29162699
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Gut. 2019 Aug;68(8):1465-1476
pubmed: 30343272
Cancer Genet. 2015 Jul-Aug;208(7-8):374-81
pubmed: 26087898
Cancers (Basel). 2020 Jul 29;12(8):
pubmed: 32751160
Int J Mol Sci. 2021 Mar 15;22(6):
pubmed: 33804169
Pharmacol Rev. 2010 Sep;62(3):525-63
pubmed: 20716671
Chemistry. 2021 Sep 24;27(54):13481-13493
pubmed: 34269488
Nat Rev Drug Discov. 2021 Nov;20(11):839-861
pubmed: 34354255
Nat Cell Biol. 2018 Jul;20(7):811-822
pubmed: 29941929
Biochemistry. 2017 Mar 14;56(10):1536-1545
pubmed: 28221775
Future Med Chem. 2016 Apr;8(6):681-96
pubmed: 27073990
Science. 2014 May 23;344(6186):913-7
pubmed: 24700472
Cell Rep. 2020 Apr 14;31(2):107509
pubmed: 32294439
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
J Med Chem. 2020 Mar 26;63(6):2958-2973
pubmed: 32077280
SLAS Discov. 2018 Mar;23(3):225-241
pubmed: 29460707
Oncotarget. 2016 May 3;7(18):26793-805
pubmed: 27050366
Placenta. 2018 Dec;72-73:10-19
pubmed: 30501876
Trends Pharmacol Sci. 2019 Nov;40(11):818-832
pubmed: 31677919
J Clin Invest. 2012 Mar;122(3):948-62
pubmed: 22354171
Leukemia. 2016 Sep;30(9):1816-23
pubmed: 27285583
Nat Biotechnol. 2011 Oct 30;29(11):1039-45
pubmed: 22037377
Trends Pharmacol Sci. 2007 Dec;28(12):608-14
pubmed: 18023486
Nat Microbiol. 2020 Oct;5(10):1207-1216
pubmed: 32661312

Auteurs

Lin Du (L)

Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.

Brice A P Wilson (BAP)

Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.

Ning Li (N)

Center for Structural Biology, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.

Rohan Shah (R)

Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.

Masoumeh Dalilian (M)

Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.
Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States.

Dongdong Wang (D)

Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.

Emily A Smith (EA)

Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.
Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States.

Antony Wamiru (A)

Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.
Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States.

Ekaterina I Goncharova (EI)

Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.
Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States.

Ping Zhang (P)

Center for Structural Biology, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.

Barry R O'Keefe (BR)

Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.
Natural Products Branch, Development Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, Maryland 21702, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH